Mark Faupel
Fortune : 1 M $ au 31/08/2026
Fortune : 1 M $ au 31/08/2026
Mark L.
Faupel is the founder of Guided Therapeutics, Inc., founded in 1992, serving as President, CEO, CFO, COO & Director.
Dr. Faupel is also the founder of MacKay Life Sciences, Inc...
Dr. Faupel is currently a Member at Shenghuo Medical LLC.
Formerly, Dr. Faupel was a Member at the European School of Oncology.
Dr. Faupel earned a doctorate from the University of Georgia.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2025 | 4 824 361 ( 5% ) | 1 M $ | 31/08/2026 | |
| 18/03/2025 | 97 ( 18,65% ) | 22 $ | 31/08/2026 | |
| 18/03/2025 | 38 ( 8,68% ) | 9 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| GUIDED THERAPEUTICS, INC. | Directeur Général | 06/03/2023 |
Shenghuo Medical LLC | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
MacKay Life Sciences, Inc.
MacKay Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical device and associated diagnostic systems to assist in detecting breast cancer | Fondateur | 01/01/1998 |
European School of Oncology | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
MacKay Life Sciences, Inc.
MacKay Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical device and associated diagnostic systems to assist in detecting breast cancer | Health Technology |
Guided Therapeutics, Inc.
Guided Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical diagnostic products | Health Technology |
European School of Oncology | |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenghuo Medical LLC |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national